FDA approves Vir Biotechnology antibody drug for emergencies

George Scangos, President and CEO of Vir Biotechnology, joined Yahoo Finance's Julia LaRoche and Adam Shapiro to discuss the latest on the company's COVID-19 antibody treatment.